Baxter International (BAX)

Name: Baxter International (BAX)
Uploaded: 2011-06-25
Duration: 1 min 36 s
Description: Baxter International (BAX) reported that a European committee endorsed a new use for the drug Kiovig as a treatment for Multifocal motor neuropathy, a rare autoimmune disorder marked by progressive weakness in the limbs. With adoption by the European Commission Baxter will receive marketing authorization for KIOVIG MMN indication in all European Union Member States.

karmastock Follow 2

Date: 2011. 06. 25.

Shares: 0 Forwards: 0 Embeds: 1

Category: people & vlogs

Add to list

To Quicklist To Favorites

Embed video

Width

Height

Embed code:

<iframe width="640" height="480" src="//videa.hu/player?v=uM7ayKEcqcCMVVC1" allowfullscreen="allowfullscreen" webkitallowfullscreen="webkitallowfullscreen" mozallowfullscreen="mozallowfullscreen" frameborder="0"></iframe>

Create GIF

Time:

99:99 sec

Resolution:

Crop: Custom 16:9 4:3 Original

Speed (fps): 2 10 20

Create snapshot

New snapshot Download (png) Download (jpg)

Report video

Reason for rejection:

Please provide the following details precisely:

Your full legal name, which typically consists of a surname and a given name, as it appears on a government-issued ID. Videa cannot process the request until it has this information.

The authorized person's email address.

Specify the subject of the grievance and the facts indicating a probable infringement.

I make the following legal declaration:

• I declare that I am acting in good faith, and that the information and statements contained in the notification are accurate and complete.

After verifying the request, Videa will initiate the video removal process.

REPORT

Date: 2011. 06. 25.

Shares: 0

Forwards: 0

Embeds: 1

Tags: bax • baxter • baxterinternational • kiovig • nyse:bax

Category: people & vlogs

Baxter International (BAX) reported that a European committee endorsed a new use for the drug Kiovig as a treatment for Multifocal motor neuropathy, a rare autoimmune disorder marked by progressive weakness in the limbs. With adoption by the European Commission Baxter will receive marketing authorization for KIOVIG MMN indication in all European Union Member States.